Accelrys to Present to Investors at the UBS Global Life Sciences Conference

Accelrys, Inc. (NASDAQ:ACCL), the leading provider of scientific business intelligence software and services, announced today that President and CEO, Mark Emkjer, will present at the UBS Global Life Sciences Conference on Tuesday, September 23, 2008 at 12:30 p.m., ET.

Conference Details

UBS Global Life Sciences Conference

Location: Grand Hyatt, New York City, New York

September 22 – 25, 2008

The company will provide a live webcast of the presentation, which can be accessed by visiting the Accelrys’ webpage at www.accelrys.com, click on the section for Investor Relations and then Event Calendar. Participants should allow approximately five to ten minutes prior to the presentation's start time to register and download any streaming media software needed to listen to the Internet webcast. Supporting material for the presentation will also be available. A replay of the presentation will be available beginning 3 hours after the end of the presentation on September 23, 2008 through October 25, 2008.

About Accelrys, Inc.

Accelrys develops and commercializes scientific business intelligence software for the aggregation, mining, integration, analysis, modeling and simulation, management and interactive reporting of scientific data. Our solutions are used by biologists, chemists, materials scientists, and information technology professionals for product design as well as drug discovery and development. Our technology and services are designed to meet the needs of today’s leading research and development organizations including leading commercial, government and academic organizations. Many of the largest pharmaceutical, biotechnology, chemical, energy, aerospace and consumer packaged goods companies worldwide use our solutions. Accelrys is headquartered in San Diego, California. For more information about Accelrys, visit its website at http://www.accelrys.com/.